Cannabis Law Report

NOVEMBER 17, 2022

The Finnish Medicines Agency (Fimea) has granted Clairvoyant Therapeutics, a Canadian drug company, permission to study the effects of psychedelic drug therapies for the treatment of alcohol addiction. Fimea’s approval marks the first time psychedelic drug trials will be carried out in Finland.

Therapy 52

Therapy Clinical Trials Treatment Medicine 52

Canna Law Blog

NOVEMBER 27, 2021

—is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies. Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. The post DMT Therapy: Coming to a Clinic Near You?

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

JUNE 7, 2021

Always consult a physician before attempting alternative therapies. But what are the medicinal benefits associated with this synthetic substance which led to the FDA’s support? When consumed therapeutically, MDMA is administered through a process known as MDMA-Assisted Therapy. Conditions That Could Benefit from MDMA Therapy .

Therapy 85

Therapy Treatment Conditions Clinical Trials 85

Cannabis Law Report

SEPTEMBER 3, 2020

The post Dr. Bronner’s launches Heal Soul campaign in support of psychedelic-assisted therapy and medicine first appeared on Cannabis Law Report. Bronner’s, family-owned maker of the top-selling natural brand of soap in North America, has … Read More.

Therapy 59

Therapy Medicine Law Cannabis 59

Medicinal Marijuana Association

FEBRUARY 14, 2024

Imagine a garden of possibilities blooming for your furry companions with the help of cannabis in veterinary medicine. Consulting with a veterinarian experienced in cannabis therapy can help you determine the right dosage and products to effectively stimulate your pet’s appetite.

Pets 98

Pets Medicine Treatment Conditions 98

Medicinal Marijuana Association

FEBRUARY 14, 2024

Imagine a garden of possibilities blooming for your furry companions with the help of cannabis in veterinary medicine. Consulting with a veterinarian experienced in cannabis therapy can help you determine the right dosage and products to effectively stimulate your pet’s appetite.

Pets 95

Pets Medicine Treatment Conditions 95

Canna Law Blog

JULY 18, 2020

corporate practice of medicine issues and medical ventures. corporate practice of medicine issues and medical ventures. The post Ketamine, Psilocybin and New Drug Therapies: The Webinar Video Replay appeared first on Harris Bricken. federal and state controlled substances laws and regulations.

Therapy 60

Therapy Decriminalization Medicine Law 60

Canna Law Blog

JUNE 6, 2020

As the legal and regulatory frameworks of those industries begin to solidify, new opportunities are emerging for the commercialization and research of new drug therapies and alternative medicine—everything from ketamine infusion clinics to psilocybin decriminalization. Ketamine Management Services Organizations: The California Puzzle.

Therapy 56

Therapy Decriminalization Medicine Hemp 56

Cannabis Law Report

AUGUST 23, 2022

On Tuesday, Mind Medicine Australia (MMA) announced that it had received an initial donation of AUD$1 million from a philanthropist called the Hunt Family Foundation for its new fund to support the development of observational trials investigating psychedelic-assisted therapies.

Medicine 52

Medicine Therapy 52

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Thus, providing a new pathway for patients to access psychedelic treatment, and another example of the medicinal approach to psychedelic legalization. Timeline of Medicinal Legalization in Canada.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Canna Law Blog

JUNE 15, 2020

As the legal and regulatory frameworks of those industries begin to solidify, new opportunities are emerging for the commercialization and research of new drug therapies and alternative medicine—everything from ketamine infusion clinics to psilocybin decriminalization. Ketamine Management Services Organizations: The California Puzzle.

Therapy 52

Therapy Decriminalization Medicine Hemp 52

Veriheal

APRIL 3, 2024

Naropa University in Boulder, Colorado, has created an exciting new initiative for students: a minor in psychedelic studies, designed to train those who want to practice psychedelic-assisted therapy and other related careers. The minor is a bachelor of arts program encompassing 12 total credits. Naropa University is a unique institution. .

Therapy 67

Therapy Education Programs Medicine 67

Veriheal

FEBRUARY 18, 2021

Psychedelics and music have long had a love affair but now, their relationship stands to take on a more therapeutic role and Johns Hopkins University School of Medicine is here for it. The university has conducted research that studied the best music to include in psychedelic therapy. What is Psychedelic Therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

MAY 29, 2022

ACT government considers Mind Medicine Australia reform to allow psychedelics. The ACT government is considering legislation changes to allow MDMA-assisted therapy to treat post-traumatic stress disorder and psilocybin to treat depression. The Canberra Times reports.

Medicine 52

Medicine Therapy Treatment Legislation 52

Cannabis Law Report

MARCH 18, 2023

Click HERE to register for our upcoming FREE Q&A webinar on ketamine regulations and the future of therapeutic psychedelic medicines! While there are still many unknowns concerning how psilocybin and MDMA-based drug therapies will be regulated, we believe that many of the same […]

Medicine 52

Medicine Therapy 52

Veriheal

JUNE 20, 2023

In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine. Always consult a physician before attempting alternative therapies.

Medicine 98

Medicine Research and Development Treatment Conditions 98

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

Cannabis Law Report

FEBRUARY 27, 2022

Melbourne-based medicinal cannabis product developer Incannex (ASX: IHL) has officially landed on the US stock exchange Nasdaq, hoping its dual listing will attract an expanded pool of investors. Food and Drug Administration approval for all of our therapies and to bringing these innovative medicines to patients in need.”.

Medicine 52

Medicine Research and Development Therapy Pharmaceutical 52

Cannabis Law Report

AUGUST 19, 2021

18, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announces it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, with research to be led by Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, Dr. Matthew W. DENVER, Aug. Johnson, Ph.

Medicine 98

Medicine Research and Development Therapy Pharmaceutical 98

Veriheal

AUGUST 16, 2021

Cannabis as a Medicine Isn’t Just Balms and Blunts. The post NFL to Award Research Grant to Investigate Cannabis Therapy appeared first on Cannabis Central. Some people have a miscued perception of how cannabis would help NFL players with pain. The NFL supports cannabis; why can’t you?

Therapy 104

Therapy Chronic Pain Research and Development Treatment 104

Cannabis Law Report

JULY 13, 2022

Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Cannabis Law Report

JUNE 24, 2021

Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Initially, Aurora supplied the medicines, a Canadian firm that was replaced in 2019 by Canopy Growth-Spectrum Pharmaceutics. Complementary therapy.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

SEPTEMBER 17, 2022

– September 15, 2022) – HealingMaps, an informative and trusted psychedelic therapy search site announced today the close of $1 Million USD in seed round funding from eight investors. As the brain health megatrend takes hold, HealingMaps will be THE go-to website for PaaM (psychedelics as a medicine) and neuro-wellness.”

Therapy 52

Therapy Education Patients Treatment 52

Cannabis Law Report

AUGUST 22, 2021

a biotechnology company dedicated to the development and commercialization of psychedelic medicines, today announced its exclusive license within the entire psychedelic industry of two major patents that will significantly advance the medical application of psychedelic compounds. MIAMI , Aug. ” About Psycheceutical, Inc.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Veriheal

JANUARY 18, 2024

Cannabis nurses are crucial in bridging the gap between traditional healthcare and emerging cannabis therapies. These nurses also offer valuable insights on integrating cannabis therapies into various healthcare settings, including dispensaries, primary care clinics, and specialized pain management centers. So what does it all mean?

Education 113

Education Therapy Patients Research and Development 113

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. ” Patients were most likely to report overall reductions in pain and overall improvements in their quality of life following cannabis therapy.

Patients 279

Patients Therapy Data Safety 279

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

MARCH 28, 2023

Workshop: Reducing the Impact of Bias on Therapy, Education, & Training d. Chacruna Courses a. Diversity, Culture and Social Justice in Psychedelics (Spring Semester) b. The Science of Psychedelic Healing c. Roots of Psychedelic […]

Medicine 52

Medicine Therapy Education 52

Cannabis Law Report

JULY 19, 2021

First-of-its-kind universal milliliter to milligram calculation has potential to transform rapidly growing plant-based medicines sector. The post RYAH Group Partners with the University of Milan to Develop Conversion Measurement Standards for Dry Herb Inhalation Therapies appeared first on CannabisFN. www.InvestorBrandNetwork.com.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

MAY 25, 2022

May 25, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate with a unanimous bipartisan vote. 20210SB1186_96.

Medicine 52

Medicine Legislation Chronic Pain Access 52

Cannabis Life Network

OCTOBER 16, 2019

Throughout its history, there have been countless documents recording Cannabinoid Therapies medical uses for ailments ranging from menstrual […]. The post Cannabinoid Therapies: Mental Health Treatment is Going Holistic appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.

Therapy 50

Therapy Treatment Cannabinoids History 50

Cannabis Law Report

FEBRUARY 16, 2022

A Journey Through the Psychedelic Revival: The Current Landscape of Psychedelic Medicine. A Journey Through the Psychedelic Revival: The Future of Psychedelic Medicine. A Journey Through the Psychedelic Revival: Access to Psychedelic Medicine. To register for this presentation and the other ones, please visit their website.

Events 52

Events Medicine Therapy Access 52

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52